We developed a cost‐effective methylation‐specific droplet digital PCR multiplex assay containing tissue‐conserved and tumor‐specific methylation markers. The assay can detect circulating tumor DNA with high accuracy in patients with localized and metastatic colorectal cancer.
Luisa Matos do Canto +8 more
wiley +1 more source
Real-time prediction of soil bearing capacity in clayey soils using drilling parameters and statistical modeling. [PDF]
Pande P +5 more
europepmc +1 more source
Statistical modeling of multipath clusters in an office environment [PDF]
Joseph, Wout +2 more
core +1 more source
Combining PTEN protein assessment and transcriptomic profiling of prostate tumors, we uncovered a network enriched in senescence and extracellular matrix (ECM) programs associated with PTEN loss and conserved in a mouse model. We show that PTEN‐deficient cells trigger paracrine remodeling of the surrounding stroma and this information could help ...
Ivana Rondon‐Lorefice +16 more
wiley +1 more source
Corrigendum to "Stable isotope and multi-elemental analysis combined with statistical modeling for saffron origin authentication" [Food Chem.: X 31 (2025) 103196]. [PDF]
Terro C +10 more
europepmc +1 more source
Next‐generation proteomics improves lung cancer risk prediction
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj +4 more
wiley +1 more source
A comparison of semi-parametric statistical modeling approaches to dynamic classification of irregularly and sparsely sampled curves. [PDF]
Deneer R +6 more
europepmc +1 more source
Editorial: Mathematical and statistical modeling of infection and transmission dynamics of viral diseases. [PDF]
Oshinubi K +3 more
europepmc +1 more source
Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute +17 more
wiley +1 more source
Tinnitus constancy and self-reported severe headache or migraine symptoms in peri- and postmenopausal women: a statistical modeling and machine learning analysis. [PDF]
Jiang L, Cui Y, Du H.
europepmc +1 more source

